SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-17-069957
Filing Date
2017-11-21
Accepted
2017-11-21 16:57:14
Documents
6
Group Members
AUGUSTINE LAWLORCHRISTOPHER MIRABELLIDOUGLAS E. ONSIHEALTHCARE PARTNERS IX, L.P.HEALTHCARE VENTURES IX, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D a17-27431_1sc13d.htm SC 13D 197741
2 EX-99.1 a17-27431_1ex99d1.htm EX-99.1 35834
3 EX-99.2 a17-27431_1ex99d2.htm EX-99.2 293848
4 EX-99.3 a17-27431_1ex99d3.htm EX-99.3 153079
5 EX-99.4 a17-27431_1ex99d4.htm EX-99.4 72968
6 EX-99.5 a17-27431_1ex99d5.htm EX-99.5 19668
  Complete submission text file 0001104659-17-069957.txt   774944
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 102 CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 102 CAMBRIDGE MA 02142 617.252.4343
HealthCare Ventures IX, L.P. (Filed by) CIK: 0001490245 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Subject) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90188 | Film No.: 171217503
SIC: 2834 Pharmaceutical Preparations